Healthequity Inc’s recently made public that its Director SELANDER ROBERT W unloaded Company’s shares for reported $0.45 million on Apr 09 ’25. In the deal valued at $77.65 per share,5,750 shares were sold. As a result of this transaction, SELANDER ROBERT W now holds 84,969 shares worth roughly $7.66 million.
Then, Stephen Neeleman bought 9,019 shares, generating $720,433 in total proceeds.
Before that, Delano Ladd bought 6,991 shares. Healthequity Inc shares valued at $558,437 were divested by the Officer at a price of $79.88 per share.
Raymond James upgraded its Healthequity Inc [HQY] rating to a Strong buy from a an Outperform in a research note published on March 25, 2025; the price target was decreased to $115 from $120. A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in early December with a ‘”an Outperform”‘ rating. Goldman began covering HQY with “Neutral” recommendation on November 15, 2024. JMP Securities started covering the stock on April 04, 2024. It rated HQY as “a Mkt outperform”.
Price Performance Review of HQY
On Tuesday, Healthequity Inc [NASDAQ:HQY] saw its stock fall -1.40% to $90.14. Over the last five days, the stock has gained 4.30%. Healthequity Inc shares have fallen nearly -6.06% since the year began. Nevertheless, the stocks have risen 13.03% over the past one year. While a 52-week high of $115.59 was reached on 02/13/25, a 52-week low of $65.01 was recorded on 04/07/25. SMA at 50 days reached $90.44, while 200 days put it at $90.59.
Levels Of Support And Resistance For HQY Stock
The 24-hour chart illustrates a support level at 89.37, which if violated will result in even more drops to 88.60. On the upside, there is a resistance level at 90.93. A further resistance level may holdings at 91.72. The Relative Strength Index (RSI) on the 14-day chart is 55.54, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 4.64, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 20.10%. Stochastics %K at 84.24% indicates the stock is a selling.
The most recent change occurred on April 02, 2024 when JP Morgan resumed its ‘”an Overweight”‘ rating for the stock and retained the price target to $108.
